Hemogenyx stock rises on GBP570,000 fundraise for Chimeric trials
(Alliance News) - Hemogenyx Pharmaceuticals PLC on Tuesday said it has raised funds to continue phase 1 clinical trials, through an off-market allotment to its chief executive officer. Read More